Literature DB >> 22431822

Treatment outcome of HIV-associated tuberculosis in a resource-poor setting.

Ngozi A Ifebunandu1, Kingsley N Ukwaja, Samuel N Obi.   

Abstract

Nigeria is among the countries with the world's highest tuberculosis (TB) burden, and HIV/TB co-infection is an important cause of mortality. We evaluate the treatment outcome of HIV-infected TB patients in Abakaliki, Nigeria. A retrospective cohort study of all TB patients registered at a tertiary hospital between January 2006 and December 2010 was conducted. Of 671 TB patients, 189 (28.2%) were HIV co-infected. Of these, 147 (77.8%) had pulmonary TB and 42 (22.2%) had extra-pulmonary TB. The overall treatment success rate was 52.4% (n = 99) and the defaulted in treatment rate was 30.2% (n = 57). Twenty-one (11.1%) died, and one (0.5%) had treatment failure. Younger age group (<15 years; P = 0.0024) and smear-positive status (P = 0.0056) were independent predictors of successful treatment. TB/HIV co-infection is associated with high mortality and alarming default rates during treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22431822     DOI: 10.1258/td.2011.110421

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  16 in total

1.  Five years retrospective cohort analysis of treatment outcomes of TB-HIV patients at a PEPFAR/DOTS Centre in South Eastern Nigeria.

Authors:  Omotowo I Babatunde; Ekwueme O Christiandolus; Eke C Bismarck; Obi I Emmanuel; Agunwa C Chike; Eyisi I Gabriel
Journal:  Afr Health Sci       Date:  2016-09       Impact factor: 0.927

2.  Prevalence and associated factors of TB/HIV co-infection among HIV Infected patients in Amhara region, Ethiopia.

Authors:  Aweke Abebaw Mitku; Zelalem Getahun Dessie; Essey Kebede Muluneh; Demeke Lakew Workie
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

3.  Getting to 90-90-90 in paediatric HIV: What is needed?

Authors:  Mary-Ann Davies; Jorge Pinto; Marlène Bras
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396

4.  The high cost of free tuberculosis services: patient and household costs associated with tuberculosis care in Ebonyi State, Nigeria.

Authors:  Kingsley N Ukwaja; Isaac Alobu; Chika Lgwenyi; Philip C Hopewell
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

5.  Factors associated with death during tuberculosis treatment of patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon: an 8-year hospital-based retrospective cohort study (2006-2013).

Authors:  Ako A Agbor; Jean Joel R Bigna; Serges Clotaire Billong; Mathurin Cyrille Tejiokem; Gabriel L Ekali; Claudia S Plottel; Jean Jacques N Noubiap; Hortence Abessolo; Roselyne Toby; Sinata Koulla-Shiro
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

6.  Profile, Outcomes, and Determinants of Unsuccessful Tuberculosis Treatment Outcomes among HIV-Infected Tuberculosis Patients in a Nigerian State.

Authors:  Daniel Chukwunweolu Oshi; Sarah Nakalema Oshi; Isaac Alobu; Kingsley Nnanna Ukwaja
Journal:  Tuberc Res Treat       Date:  2014-11-16

7.  Interactions between leprosy and human immunodeficiency virus: More questions than answers.

Authors:  Kingsley Nnanna Ukwaja
Journal:  J Neurosci Rural Pract       Date:  2015 Apr-Jun

8.  Survival rates of human immunodeficiency virus and tuberculosis co-infected patients.

Authors:  Ghodratollah Roshanaei; Masoud Sabouri Ghannad; Mohammad Saatchi; Salman Khazaei; Mohammad Mirzaei
Journal:  Jundishapur J Microbiol       Date:  2014-06-01       Impact factor: 0.747

9.  Tuberculosis Treatment Outcome in Patients with TB-HIV Coinfection in Kuala Lumpur, Malaysia.

Authors:  Diana Safraa Selimin; Aniza Ismail; Norfazilah Ahmad; Rohani Ismail; Nurul Farhana Mohd Azman; Amaleena Azman
Journal:  J Trop Med       Date:  2021-05-29

10.  Impact of HIV Status on Treatment Outcome of Tuberculosis Patients Registered at Arsi Negele Health Center, Southern Ethiopia: A Six Year Retrospective Study.

Authors:  Gebreslassie Gebremariam; Getachew Asmamaw; Muktar Hussen; Mengistu Z Hailemariam; Demissie Asegu; Ayalew Astatkie; Anteneh G Amsalu
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.